Literature DB >> 20463316

Posterior linear stromal haze formation after simultaneous photorefractive keratectomy followed by corneal collagen cross-linking.

George D Kymionis1, Dimitra M Portaliou, Vasilios F Diakonis, Georgios A Kontadakis, Maria S Krasia, Anastasios G Papadiamantis, Efekan Coskunseven, Aristofanis I Pallikaris.   

Abstract

PURPOSE: To report the development of posterior linear stromal haze after simultaneous photorefractive keratectomy (PRK) followed by corneal collagen cross-linking (CXL).
METHODS: Combined simultaneous customized PRK followed by corneal collagen cross-linking was performed in 23 patients (28 eyes) with keratoconus. Corneas were examined biomicroscopically and by means of confocal microscopy before surgery and 1, 3, 6, 9, and 12 months after surgery.
RESULTS: Posterior linear stromal haze was observed clinically (slit lamp biomicroscopy) one month after surgery in 13 of 28 eyes (46.42%). No corneal edema or anterior haze formation was evident. Confocal microscopy revealed in those 13 eyes a hyperreflective area at the level of the posterior stroma 1 month after combined treatment. Both slit lamp examination and corneal confocal microscopy follow-up demonstrated a gradual anterior movement and a decrease in reflectance of this finding. At 12 months this posterior linear stromal haze, despite its anterior movement and decreased density, did not completely disappear at slit lamp and confocal microscopy analysis.
CONCLUSIONS: Posterior linear stromal haze formation may appear after simultaneous PRK followed by CXL in patients with keratoconus. This finding seems to gradually become less dense and slowly moves toward the anterior stroma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463316     DOI: 10.1167/iovs.09-5105

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

Review 1.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

2.  Comparison of corneal keratocytes before and after corneal collagen cross-linking in keratoconus patients.

Authors:  Mohammad-Naeim Aminifard; Hoda Khallaghi; Mahdi Mohammadi; Reza Jafarzadeh
Journal:  Int Ophthalmol       Date:  2015-02-04       Impact factor: 2.031

Review 3.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

Review 4.  Progress of corneal collagen cross-linking combined with refractive surgery.

Authors:  Na Li; Xiu-Jun Peng; Zheng-Jun Fan
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

5.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

6.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

7.  Trans-epithelial versus conventional corneal collagen crosslinking: A randomized trial in keratoconus.

Authors:  Shah Nawaz; Shikha Gupta; Varun Gogia; N K Sasikala; Anita Panda
Journal:  Oman J Ophthalmol       Date:  2015 Jan-Apr

8.  Nodular epithelial hyperplasia after photorefractive keratectomy followed by corneal collagen cross-linking.

Authors:  Ayla Bogoni; Liberdade Cezaro Salerno; Vinícius Coral Ghanem; Ramon Coral Ghanem
Journal:  Case Rep Ophthalmol Med       Date:  2013-04-04

Review 9.  Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives.

Authors:  Leonardo Mastropasqua
Journal:  Eye Vis (Lond)       Date:  2015-11-29

10.  Long-Term Follow-Up of Combined Photorefractive Keratectomy and Corneal Crosslinking in Keratoconus Suspects.

Authors:  George Kymionis; George Kontadakis; Michael Grentzelos; Myrsini Petrelli
Journal:  Clin Ophthalmol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.